- Cello, the health and consumer strategic marketing group, reports good trading for the year ended 31 December, with revenues and headline profits in line with consensus market expectations.


- Cello Health maintains good like-for-like revenue growth and a competitive profit margin

- Cello Signal also delivers good like-for-like revenue growth, with an improving profit margin

- Cello Signal benefits from aligning its core activities behind the client-facing Signal brand - The Group ends the year with net debt below GBP5.0m

- Strong bookings momentum from Q4 2015 provides good visibility for the start of 2016

The group says 2016 has begun with good bookings momentum from the last quarter of 2015 and, at this early stage of the year, the Board is confident of a good trading year ahead for the group.

The preliminary results for the year ended 31 December will be announced on 17 March.

At 8:05am: [LON:CLL] Cello Group PLC share price was +1.5p at 82p

Story provided by